RxDoctor Payments Data

Divya Sree Madhuramthakam, MD

Internal Medicine · South Euclid, OHNPI 1073017943

Payments from drug & device makers

$1,916in general payments, 2019–2025

Across 102 payments — averaging $18.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$192
  • AbbVie$179
  • Novo Nordisk$174
  • Astellas Pharma US Inc$159
  • Abbott$130
  • Exact Sciences$108
  • plus $975 from 22 others

What the payments were for

  • Food & beverage$1,916100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,916 in reported general payments places this provider in the 80th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$44,442
Medicare patients
163
Services billed
523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$33,497
XareltoRivaroxaban28$28,595
JardianceEmpagliflozin36$28,382
JanumetSitagliptin Phos/Metformin Hcl30$22,551
MounjaroTirzepatide14$20,045
EliquisApixaban24$17,788
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$12,866
EntrestoSacubitril/Valsartan17$11,865
JanuviaSitagliptin Phosphate13$8,598
SymbicortBudesonide/Formoterol Fumarate14$4,566
Atorvastatin Calcium522$4,473
LumiganBimatoprost12$3,158
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$2,766
Amlodipine Besylate450$2,426
Losartan Potassium255$2,213

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$174$33,49731 claims
Johnson & JohnsonXarelto$78$28,59528 claims
Boehringer IngelheimJardiance$19$28,38236 claims
Lilly USA, LLCMounjaro$60$20,04514 claims
PfizerEliquis$94$17,78824 claims
GSKTrelegy Ellipta$65$12,86620 claims
NovartisEntresto$35$11,86517 claims
AstraZenecaSymbicort$192$4,56614 claims
AbbVieLumigan, Synthroid$179$3,61327 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in South Euclid

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →